The Human Biology in Medical Field

Archive for the ‘cancer’ Category

Lung growth is the principal instigate of sarcoma deaths in both women and men in the United States and throughout the world. Lung melanoma has surpassed breast plague as the leading motive of sarcoma deaths in women.

In the United States in 2007, 160,390 people were projected to die from lung melanoma, which is more than the number of deaths from colorectal, breast, and prostrate plague mutual.

Only about 2% of those diagnosed with lung canker that has swell to other areas of the body are breathing five existence after the diagnosis, while the survival tariff for lung cancers diagnosed at a very early point are senior, with about 49% ongoing for five years or longer.

Some lung tumors are metastatic from cancers elsewhere in the body. The lungs are a customary site for metastasis. If this is the instance, the plague is not considered to be lung disease. For example, if prostrate lump spreads via the bloodstream to the lungs, it is metastatic prostrate scourge (a derived plague) in the lung and is not called lung disease.

Cancer occurs when customary cells undergo a transformation that causes them to grow and multiply lacking the habitual reins. The cells form a crowd or growth that differs with the surrounding tissues from which it arises. Tumors are hazardous because they take oxygen, nutrients, and distance from wholesome cells.

About 90% of lung cancers surface due to tobacco use. Cigarette smoking is the most important grounds of lung growth. Research as far back as the 1950s evidently established this relationship. Cigarette smoked contains more than 4,000 chemicals, many of which have been identified as causing sarcoma. A role who smokes more than one backpack of cigarettes per day has an imperil of developing lung disease 20-25 time greater than somebody who has never smoked.

However, Once a person quits smoking, his or her endanger for lung disease regularly decreases. About 15 years after quitting, the expose for lung pest decreases to the equal of someone who never smoked. Cigar and channel smoking also increases the endanger of lung scourge but not as much as smoking cigarettes. Most lung tumors are spiteful. This means that they invade and end the strong tissues around them and can widen throughout the body.

The tumors can also range to adjoining lymph nodes or through the bloodstream to other organs. This means is called metastasis. When lung melanoma metastasizes, the lump in the lung is called the major lump, and the tumors in other parts of the body are called minor tumors or metastatic tumors.

Adenocarcinoma (a NSCLC) is the most regular variety of lung sarcoma, making up 30%-40% of all luggage. A subtype of adenocarcinoma is called bronchoalveolar cubicle carcinoma, which creates a pneumonia-like appearance on chest x-emission. Squamous unit carcinoma (a NSCLC) is the support most normal print of lung scourge, making up about 30% of all lung cancers. Large section melanoma (another NSCLC) makes up 10% of all suitcases. SCLC makes up 20% of all suitcases. And lastly, Carcinoid tumors account for only 1% of all gear.

Lung cancers are regularly alienated into two highest groups that account for about 95% of all cases. The gulf into groups is based on the style of cells that make up the blight. About 5% of lung cancers are of bloody group types, including carcinoid growth, lymphoma, and others.

The two focal types of the booth characterized lung canker mass of the tumor when viewed under the microscope. They are called small faction lung growth (SCLC) and non-small cell lung blight (NSCLC). NSCLC includes several subtypes of tumors. SCLCs are excluding communal, but they grow more swiftly and are more possible to metastasize than NSCLCs. Often, SCLCs have already range to other parts of the body when the canker is diagnosed.

Up to one-fourth of all people with lung scourge may have no symptoms when the menace is diagnosed. These cancers mostly are identified incidentally when a chest x-ray is performed for another reason. The adulthood of people, however, acquire symptoms. The symptoms are dues to tell things of the major tumor, to things of metastatic tumors in other parts of the body, or to disturbances of hormones, blood, or other systems caused by the plague.

Symptoms of prime lung cancers compose cough, coughing up blood, chest bind, and dumpiness of breath. Symptoms of metastatic lung tumors depend on the position and mass. About 30%-40% of people with lung bane have some symptoms or cipher of metastatic disease.

A cough that does not go away or gets inferior over time should be evaluated by a vigor-attention source. Also, Coughing up blood (hemoptysis) occurs in a significant number of people who have lung blight. Any total of coughed-up blood is start for disturb. Chest hurt is a symptom in about one-fourth of people with lung melanoma. The bind is dull, aching, and persistent and may concern other structures surrounding the lung.

Additionally, tininess of breath typically fallout from an obstacle to the flow of air in part of the lung, collection of fluid around the lung (pleural effusion), or the spread of tumor throughout the lungs. Wheezing or hoarseness may gesture blockage or inflammation in the lungs that may go along with bane. Finally, Repeated respiratory infections, such as bronchitis or pneumonia, can be a show of lung cancer.

Incoming search terms:

• sarcoma in the lungs
• Cancer occurs when:
• Lung Cancer Fluid around Lungs
• cancer occurs when
• Sarcoma of the Lungs
• Sarcoma in lung
• sarcoma cancer in the lungs
• sarcoma cancer in the lung
• lung cancer and fluid on the lungs
• fluid in lung causes cancer

Cancer of the gall bladder is a very uncommon condition. Gall bladder cancer, also called carcinoma of the gall bladder. The gallbladder is a pear-shaped limb underneath the liver that collects and stores bile (a fluid made by the liver to digest fat). Gallbladder cancer starts in the intimate layer of tissue and spreads through the outer layers as it cultivates. Gall bladder cancer tends to spread to nearby organs and tissues such as the liver or small intestine. It also extends through the lymph system to lymph nodes in the region of the liver (porta hepatis). Gallbladder cancer is most frequently seen in older patients, with a median age at diagnosis of 62-66 years.

It arises more often in women’s. Gallbladder cancer is the fifth most common GI cancer in the United States. Gall bladder cancer is very rare affecting only 7,100 people in the United States per year. Gallbladder cancer infrequently produces premature signs and symptoms. When symptoms do seen, they often look like those of other, more common, gallbladder problems such as gallstones or infection. The bulk of these cancers are “adenocarcinomas”, with subtypes such as papillary, nodular, and tubular, depending on the appearance of the tumor cells under the microscope.

Less common subtypes comprise: squamous cell, signet ring cell, and adenosquamous (adenoacanthoma). Gallbladder cancer symptoms consist of jaundice and fever. Most gall bladder cancers are only revealed when they have reached fairly a late stage. They can reason a diversity of symptoms, including sickness and high temperatures, and sudden pain (which may come and go) in the upper right-hand side of the abdomen. The abdomen is the cavity containing several organs including the stomach, gall bladder and liver. Treatment may also depend on the age and general health of the patient and whether the cancer is causing symptoms.

Surgery is a common treatment for cancer of the gallbladder if it has not broadened to surrounding tissues. Laparoscopy is frequently used to eliminate the gallbladder as a treatment for gallstones or chronic irritation of the gallbladder. This operation is called a laparoscopic cholecystectomy. Chemotherapy employs drugs to destroy cancer cells. Radiation therapy utilizes high-energy X-rays to kill cancer cells and minimize tumors. Radiation for gallbladder cancer generally comes from a machine outside the body (external beam radiation therapy). Radiation may be used alone or in addition to surgery.

Incoming search terms:

• porta hepatis lymph node
• high functioning gallbladder
• porta hepatis tumor
• porta hepatis lymph nodes
• High-Functioning Gallbladder
• women over strucher vedio
• radiation hepatis
• retropancreatic region and porta hepatis
• symptoms of porta hepatis
• texture of a human urinary bladder

Cancer

Cancer is abnormal and uncontrolled growth of cells in human body. The cells divide at a very faster rate and even rupture to infect other tissues. They may travel in the blood stream or the lymph fluid. There are close to 100 different types of cancer. They are named after the organ they infect or originate from. Broadly cancer can be categorized as

1.       Carcinoma

2.       Sarcoma

3.       Leukemia

4.       Lymphoma and Myeloma

5.       Central Nervous System (CNS) Cancer

Carcinoma is a cancer that begins in skin and the tissues lining internal organs. Sarcoma is cancer of the bones, cartilages, blood vessels or muscle. Leukemia is blood cancer and CNS cancer is the cancer of brain and spinal cord. Other common types of cancers are bladder cancer, breast cancer, colon and rectal cancer, endometrial cancer, renal cell cancer, lung cancer, pancreatic cancer, prostate cancer and thyroid cancer. Cancer can be detected by strange growth of body tissues, biopsy and other tests.

Stages in Cancer

All forms of Cancer start at the cellular level. In a normal body, whenever there is a damaged cell, it is discarded by the body. Cancer damages the genetic composition of a cell and alters the DNA coding. Once the DNA of a cell is changed by a carcinogen, the cells do not die and such cells accumulate to form a callus of dead cells called tumor. There are 2 types of tumors

1.       Benign tumor

2.       Malignant tumor

Benign tumors can be treated by surgically treating them by removal and they do not spread over to other parts of the body. However, if benign tumor starts spreading, they are termed malignant and they also infest the neighbor organs and cells. Malignant tumors are cancerous and their spreading to other organs is termed as metastasis.

Causes of Cancer

Cancer causing agents are called carcinogens. Smoking, tobacco, inheritance, exposure to radioactive substances, exposure to UV Radiations, unsafe sex, lack of physical activity, blood transfusion and environmental factors are the major causes of different forms of cancer.

1.       Smoking is responsible for one-third of all cancer fatalities. Almost all cases of lung cancer can be associated to smoking. Smoking Is also known to cause kidney, cervical and stomach cancer.

2.       Chewing tobacco causes oral cancer. Like smoking it may also triggers cancerous activity in kidney, cervical and stomach. It is also known to cause acute myeloid leukemia.

3.       If you have a family history of cancer then it is very likely that you have inherited a mutant gene. It stays in passive mode in most of the cases and in such cases you need to be extra cautious

4.       People who work at nuclear plant bear a great risk of gene mutation and this may cause various cancers.

5.       Exposure to UV Rays from sun is known to cause skin cancer.

6.       Unsafe sex causes infection by human papillioma virus or HPV. HPV increases the risk of cervical, vulvar and vaginal cancer.

7.       Exercising regularly helps fight obesity which is known to cause prostate, colon, breast, endometrial and lung cancer.

8.       If the blood donor has any form of cancer, he greatly has the chances of transferring cancerous cells through his blood to the recipient.

9.       Environmental factors like asbestos dust, exposure to benzene, gasoline or various pollutants is also known to causes cancers.

Treatment

Cancer can be treated by the following methods:

1.       Chemotherapy includes killing of micro- organisms, mutant and cancerous cells by exposure to chemicals

2.       Radio therapy or radiation therapy is used to treat certain forms of cancer by exposing the affected area or organ to ionized radiations

3.       The affected region or organ can also be surgically removed to remove and discard the cancerous cells and preventing them from spreading further

4.       Other treatment may include angiogenesis inhibitors therapy by cutting out blood supply to tumors, biological therapy, bone marrow transplant, peripheral blood stem cell transplant, gene therapy and targeted cancer therapies

Cancer is long-term disease that is lethal and can cost people’s lives. There are various types of cancer, some of them can be tackled, and the rest are incurable. Various types of cancer are diagnosed every year however they are so active that they attack different parts of a body. Though there are people suffering from various types of cancer, Adenocarcinoma is one of the common colon cancer found in most of the people. Each cancer has its own way of attacking the body parts and leave different types of symptoms. Cancer can be severe and unbearable in some cases which give people agonizing life. Cancer is basically a disease that brings several health related problems. The most common of all are skin cancer which can be simple and complex both during its course. The lists of cancer are brain cancer, eye cancer, throat cancer, lung cancer, breast cancer, endometrial cancer, stomach cancer, pancreatic cancer, kidney cancer, thyroid cancer, etc. However cancer can be controlled with medications but cannot be cured completely.

Cancer has the power to affect different parts of the organ and it develops within the cell and affects the neighboring cells and tissues.  This leads to spreading of cancer to all parts of the body. During Leukemia the cancer cells comes out from the affected area and gets into blood stream due to which the blood in a body gets affected and causes blood cancer. The process where cancer cells enter the blood stream and infecting blood is called metastasis. The cancer that originates on blood cells can later affect the bone marrow and hence causing bone cancer.

Breast cancer is common in women and more than three million women are suffering from this disease. If this disease is not diagnosed properly than the breast needs to be removed in order to avoid spreading of this disease in different parts of the body.

Gastrointestinal cancer is the worst types of cancer that affect from esophagus to the end at anus. Here different parts of the organ are affected so they have different symptoms and different way of treatment. Endocrine cancer is a different kind of cancer that is responsible for hormonal activity which affects the internal part of the body.  Endocrine cancer includes thyroid cancer which is the most common one in this category.

Eye cancer is another type of cancer that affects the retina of an eye and cause blindness. This cancer can affect both children and adults.

Head and neck cancer is the worst cancer at worst place. This cancer attacks mouth, throat and nose which could be quit irritating and gives uneasy feelings. This is mostly generated by cigarette smoking.  Lung cancer and respiratory cancer are also the impact of cigarette smoking.

The most common and the irritating cancer of all are skin cancer. This usually happen due to Ultra violet rays from the sun.

There are plenty of medications available for different types of cancer however some cancer are deadly and cannot be treated.

Incoming search terms:

• blindness from a tumour
• blindness from cancer
• brain tumour blindness
• Brain tumour causes blindness

Bladder Cancer Treatment In India

Overview

Q. What is bladder cancer ?

The bladder is located in the pelvis. It collects and stores urine and has a muscular wall that allows it to contract and expand. About 90 percent of bladder cancers are transitional cell carcinoma. Squamous cell carcinoma, adenocarcinoma and small cell carcinoma account for most of the rest. Treatment options vary depending on the type of bladder case.

 
Cancer that is only in the bladder lining is called non-muscle invasive bladder cancer (NMIBC). This type of cancer is sometimes called superficial bladder cancer. More than 75 percent of bladder cancer is diagnosed as a NMIBC and it has an excellent survival rate…

Symptoms

Generally the first sign is blood in the urine. It may be visible or the amount may be so small that it can only be discovered by chemical testing (‘stix’ test).
There does not need to be blood in the urine constantly. In fact, there are often periods in which there is no evidence of blood at all. So one should not be fooled by a symptom that seems to have gone away. There may be frequent urination, stinging and pain across the pubic bone or exactly the same symptoms as in an ordinary bladder infection…

Types of bladder cancer

Transitional cell bladder cancer (TCC) is the most common type of bladder cancer. Nearly all cancers of the bladder start in the layer of cells (transitional cells) which form the lining of the bladder (transitional epithelium). These cancers are called transitional cell or urothelial cell cancers.

Bladder cancer may appear as a tumour which has grown into the muscle wall of the bladder. This is known as invasive bladder cancer…

Staging

The stage of a cancer describes its size and whether it has spread beyond its original site. Knowing the particular type and the stage of the cancer helps the doctors to decide on the most appropriate treatment.

Cancer can spread in the body, either in the bloodstream or through the lymphatic system. The lymphatic system is part of the body’s defence against infection and disease…

There are four stages to cancer of the gall bladder : -

The cancer affects only the wall of the gall bladder. Approximately 1 in 4 cancers are at this stage when they are diagnosed. The cancer has spread through the full thickness of the wall of the gall bladder, but has not spread to nearby lymph nodes or adjacent organs. The cancer has spread to lymph nodes close to the gall bladder or has spread to the liver, stomach, colon or the small bowel. The cancer has spread very deeply into two or more organs close to the gall bladder or has spread to distant lymph nodes or organs such as the liver or lungs. This is known as metastatic or secondary cancer…

Treatment

The type of treatment you are given will depend on a number of factors, including your general health, the position and size of the cancer in the gall bladder and whether the cancer has spread to other areas of the body…

Please log on to : www.indiahospitaltour.com

Send your query : Get a Quote

We Care Core Values

We have a very simple business model that keeps you as the centre.

Having the industry’s most elaborate and exclusive Patient Care and Clinical Coordination teams stationed at each partner hospital, we provide you the smoothest and seamless care ever imagined. With a ratio of one Patient Care Manager to five patients our patient care standards are unmatched across the sub continent.

Incoming search terms:

• mesastic folic disease

Bladder cancer surgery in India refers to any of several types of malignant growths of the urinary bladder. It is a disease in which abnormal cells multiply without control in the bladder. The bladder is a hollow, muscular organ that stores urine; it is located in the pelvis. The most common type of bladder cancer begins in cells lining the inside of the bladder and is called transitional cell carcinoma (sometimes urothelial cell carcinoma). Bladder cancer characteristically causes blood in the urine; this may be visible to the naked eye (frank hematuria) or detectable only by microscope (microscopic hematuria). Other possible symptoms include pain during urination, frequent urination (Polyuria) or feeling the need to urinate without results. These signs and symptoms are not specific to bladder cancer, and are also caused by non-cancerous conditions, including prostate infections and cystitis. Kidney cancer also can cause hematuria. Tobacco smoking is the main known cause of urinary bladder cancer: in most populations, smoking causes over half of bladder cancer cases in men and a sizeable proportion in women. There is a linear relationship between smoking and risk, and quitting smoking reduces the risk.In a 10-year study involving almost 48,000 men, researchers found that men who drank 1.5L of water a day had a significantly reduced incidence of bladder cancer when compared with men who drank less than 240mL (around 1 cup) per day. The authors proposed that bladder cancer might partly be caused by the bladder directly contacting carcinogens that are excreted in urine. It is postulated, therefore, that by drinking higher quantities of water, urine is more dilute, thereby reducing the chance of disease.

Diagnosis and Treatment:

The gold standard for diagnosing bladder cancer is biopsy obtained during cystoscopy. Sometimes it is an incidental finding during cystoscopy. Urine cytology can be obtained in voided urine or at the time of the cystoscopy (“bladder washing”). Cytology is very specific (a positive result is highly indicative of bladder cancer) but suffers from low sensitivity (a negative result does not exclude the diagnosis of cancer). There are newer urine bound markers for the diagnosis of bladder cancer. These markers are more sensitive but not as specific as urine cytology. They are much more expensive as well. Many patients with a history, signs, and symptoms suspicious for bladder cancer are referred to a urologist or other physician trained in cystoscopy, a procedure in which a flexible tube bearing a camera and various instruments is introduced into the bladder through the urethra. Suspicious lesions may be biopsied and sent for pathologic analysis. The treatment of bladder cancer depends on how deep the tumor invades into the bladder wall. Superficial tumors (those not entering the muscle layer) can be “shaved off” using an electrocautery device attached to a cystoscope. Immunotherapy in the form of BCG instillation is also used to treat and prevent the recurrence of superficial tumors. BCG immunotherapy is effective in up to 2/3 of the cases at this stage. Instillations of chemotherapy, such as valrubicin (Valstar) into the bladder can also be used to treat BCG-refractory CIS disease when cystectomy is not an option.

Untreated, superficial tumors may gradually begin to infiltrate the muscular wall of the bladder. Tumors that infiltrate the bladder require more radical surgery where part or all of the bladder is removed (a cystectomy) and the urinary stream is diverted. In some cases, skilled surgeons can create a substitute bladder (a neobladder) from a segment of intestinal tissue, but this largely depends upon patient preference, age of patient, renal function, and the site of the disease.

A combination of radiation and chemotherapy can also be used to treat invasive disease. It has not yet been determined how the effectiveness of this form of treatment compares to that of radical ablative surgery.

There is weak observational evidence from one very small study (84) to suggest that the concurrent use of statins is associated with failure of BCG immunotherapy.

The hemocyanin found in Concholepas concholepas blood has immunotherapeutic effects against bladder and prostate cancer. In a research made in 2006 mice were primed with C. concholepas before implantation of bladder tumor (MBT-2) cells. Mice treated with C. concholepas showed a significant antitumor effect as well. The effects included prolonged survival, decreased tumor growth and incidence and lack of toxic effects.

Follow up care:

Follow-up cancer care involves regular medical checkups that include a review of a patient’s medical history and a physical exam. Follow-up care may include imaging procedures (methods of producing pictures of areas inside the body), endoscopy (the use of a thin, lighted tube to examine the inside of the body), blood work, and other lab tests.

Follow-up care is important because it helps to identify changes in health. The purpose of follow-up care is to check for recurrence (the return of cancer in the primary site) or metastasis (the spread of cancer to another part of the body). Follow-up care visits are also important to help in the prevention or early detection of other types of cancer, address ongoing problems due to cancer or its treatment, and check for physical and psychosocial effects that may develop months to years after treatment ends. All cancer survivors should have follow-up care.

When planning a follow-up care schedule, patients should consider who will provide the follow-up care and who will provide other medical care. They should select a doctor with whom they feel comfortable. This may be the same doctor who provided the person’s cancer treatment. For other medical care, people should continue to see a family doctor or medical specialist as needed.Some people might not have a choice in who provides their follow-up care, because some insurance plans pay for follow-up care only with certain doctors and for a set number of visits. In planning follow-up care, patients may want to check their health insurance plan to see what restrictions, if any, apply to them. For further details on the Affordable cost Bladder Cancer surgery in India feel free to visit us at www.indiacancersurgerysite.com  or mail your queries at info@indiacancersurgerysite.com or talk to us international callers, at  +91 9579034639

Incoming search terms:

• degenerating urothelial cells statins
• degenerating urothelial cells

Lung cancer is the leading cause of cancer deaths in both women and men in the United States and throughout the world. Lung cancer has surpassed breast cancer as the leading cause of cancer deaths in women.

In the United States in 2007, 160,390 people were projected to die from lung cancer, which is more than the number of deaths from colorectal, breast, and prostate cancer combined.

Only about 2% of those diagnosed with lung cancer that has spread to other areas of the body are alive five years after the diagnosis, although the survival rates for lung cancers diagnosed at a very early stage are higher, with approximately 49% surviving for five years or longer.

Some lung tumors are metastatic from cancers elsewhere in the body. The lungs are a common site for metastasis. If this is the case, the cancer is not considered to be lung cancer. For example, if prostate cancer spreads via the bloodstream to the lungs, it is metastatic prostate cancer (a secondary cancer) in the lung and is not called lung cancer.

Cancer occurs when normal cells undergo a transformation that causes them to grow and multiply without the normal controls. The cells form a mass or tumor that differs from the surrounding tissues from which it arises. Tumors are dangerous because they take oxygen, nutrients, and space from healthy cells.

About 90% of lung cancers arise due to tobacco use. Cigarette smoking is the most important cause of lung cancer. Research as far back as the 1950s clearly established this relationship. Cigarette smoke contains more than 4,000 chemicals, many of which have been identified as causing cancer. A person who smokes more than one pack of cigarettes per day has a risk of developing lung cancer 20-25 times greater than someone who has never smoked.

However, Once a person quits smoking, his or her risk for lung cancer gradually decreases. About 15 years after quitting, the risk for lung cancer decreases to the level of someone who never smoked. Cigar and pipe smoking also increases the risk of lung cancer but not as much as smoking cigarettes.
Most lung tumors are malignant. This means that they invade and destroy the healthy tissues around them and can spread throughout the body.

The tumors can also spread to nearby lymph nodes or through the bloodstream to other organs. This process is called metastasis. When lung cancer metastasizes, the tumor in the lung is called the primary tumor, and the tumors in other parts of the body are called secondary tumors or metastatic tumors.

Adenocarcinoma (an NSCLC) is the most common type of lung cancer, making up 30%-40% of all cases. A subtype of adenocarcinoma is called bronchoalveolar cell carcinoma, which creates a pneumonia-like appearance on chest x-rays. Squamous cell carcinoma (an NSCLC) is the second most common type of lung cancer, making up about 30% of all lung cancers. Large cell cancer (another NSCLC) makes up 10% of all cases. SCLC makes up 20% of all cases. And finally, Carcinoid tumors account for only 1% of all cases.

Lung cancers are usually divided into two main groups that account for about 95% of all cases. These division into groups is based on the type of cells that make up the cancer. About 5% of lung cancers are of rare cell types, including carcinoid tumor, lymphoma, and others.

The two main types of lung cancer are characterized by the cell size of the tumor when viewed under the microscope. They are called small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC includes several subtypes of tumors. SCLCs are less common, but they grow more quickly and are more likely to metastasize than NSCLCs. Often, SCLCs have already spread to other parts of the body when the cancer is diagnosed.

Up to one-fourth of all people with lung cancer may have no symptoms when the cancer is diagnosed. These cancers usually are identified incidentally when a chest x-ray is performed for another reason. The majority of people, however, develop symptoms. The symptoms are due to direct effects of the primary tumor, to effects of metastatic tumors in other parts of the body, or to disturbances of hormones, blood, or other systems caused by the cancer.

Symptoms of primary lung cancers include cough, coughing up blood, chest pain, and shortness of breath. Symptoms of metastatic lung tumors depend on the location and size. About 30%-40% of people with lung cancer have some symptoms or signs of metastatic disease.

A cough that does not go away or gets worse over time should be evaluated by a health-care provider. Also, Coughing up blood (hemoptysis) occurs in a significant number of people who have lung cancer. Any amount of coughed-up blood is cause for concern. Chest pain is a symptom in about one-fourth of people with lung cancer. The pain is dull, aching, and persistent and may involve other structures surrounding the lung.

Additionally, shortness of breath usually results from a blockage to the flow of air in part of the lung, collection of fluid around the lung (pleural effusion), or the spread of tumor throughout the lungs. Wheezing or hoarseness may signal blockage or inflammation in the lungs that may go along with cancer. Finally, Repeated respiratory infections, such as bronchitis or pneumonia, can be a sign of lung cancer.

Ovarian cancer: Ovaries belongs to the womanâ??s reproductive system. They are located in the pelvis region. Ovaries are useful in producing female hormones like estrogen and progesterone. Ovaries play the main role in releasing the egg to the womb (uterus). Ovaries will stop producing eggs when woman goes through menopause by decreasing the hormone levels in the body.

Ovarian cancer occurs in the reproductive system cells, these cells are the building blocks of tissues and organs. Basically these cells grow and divide into multiple cells and they die when they grow, and new cells take their place. But due to some causes these basic life cycle of the cells gets damage and began to grow rapidly without any controlling limit. These cells form a huge mass of tissue which is called as tumor.

Ovarian tumors are of two types they are:
â?¢ Benign tumor: These tumors are not life threatening tumors. This cancer can be removed easily by surgery process.  These tumors grow in single site. They do not spread and invade other tissues around them. The benign tumor cells doesnâ??t contain metastatic characteristics( spreading nature to other parts of the body)
â?¢ Malignant tumor: These tumors are cancerous tumors. They spread to other parts of the body. These tumors can be removed but sometimes they grow back. Malignant tumors invade nearby tissues and organs. These tumors contain metastatic characters.

Ovarian cancer has three main characteristics they are:
Invasion: malignant tumors invade other nearby tissues life fallopian tube and uterus.
Shed (Break off): Ovarian cancer cells can creak off from the ovarian tumor. Breaking into abdomen can cause gastrointestinal Cancer.
Spread: These cancer cells spread to lymph nodes of pelvis, chest and abdomen by lymphatic system. These cancer cells can also spread to organs like lungs and kidneys.

When the ovarian cancer cells spreads to the other parts will form a new tumor which has the same characteristic features of the primary tumor. For example, if the ovarian cancer spreads to the lungs, the cancer cells in the lungs are actually belonging to the ovarian cancer cells. Then this disease is called as metastatic ovarian cancer.

Causes of Ovarian cancer: The exact causes for this cancer are not found but the risk factors for this ovarian cancer are identified. Here is the list of risk factors.

Risk factors for ovarian cancer:
â?¢ No pregnancy: Lack of pregnancy in woman can have 2 to 3 times of higher risk in facing ovarian cancer that pregnant woman.
â?¢ Obesity: Woman who weight more than 50 pounds have 10 times of higher risk in facing ovarian cancer.
â?¢ Early puberty: Woman who faces early puberty before 12 years of age have more risk factors for ovarian cancer.
â?¢ Late menopause: Woman who goes for menopause after 50 years of age have more chances of causing ovarian cancer.
â?¢ Family history: Family history also can be factor in causing ovarian cancer. So please be sure in taking screening tests for diagnosing of ovarian cancer.
â?¢ High estrogen level: Women who intakes high level of unopposed estrogen will increase the risk factor of causing ovarian cancer
â?¢ Using of breast cancer drugs: Tamoxifen is a kind of anti-cancer drug mostly useful in curing breast cancer. If the usage of this drug is in excess mode, then there will be increase in chances of having ovarian cancer.
â?¢ Cancers like endometrial and colon increases the chances of having ovarian cancer.

Ovarian cancer symptoms and signs:
â?¢ Abnormal bleeding of vagina
â?¢ Weight loss
â?¢ Pelvic pain
â?¢ Swelling in pelvic pain
â?¢ Pain in pelvis, abdomen and legs
â?¢ Swollen abdomen
â?¢ Nausea
â?¢ Constipation
â?¢ Fatigue
â?¢ Unusual menopause
â?¢ Urinate often
â?¢ Shortness of breath

These are the symptoms found during the developing stage of the ovarian cancer. Please be sure in taking screening test for diagnosing the severity of the disease.

Treatment methods for ovarian cancer: Surgery, chemotherapy and radiation therapy are best treatment methods available for treating this ovarian cancer. Depending on the severity of the cancer, your doctor describes the treatment choices.

Surgery: Surgery is the main therapy for  curing of ovarian cancer in the early stage. This surgery process is carried by identifying the first staging of the ovarian cancer. Surgery is carried by making a long incision in the abdomen area to remove the ovarian cancer tumor. Surgery will be taken place only if the ovarian tumor located in only one part of the body. During this surgery process the damaged fallopian tubes, uterus, omentum, and lymph nodes and nearby tissues are also removed along with the ovaries.  During some cases, the major portion of other infected organs will be removed for avoiding spreading of the disease throughout the body.

Radiotherapy: This treatment is based on the extent of the disease.  Radiotherapy is a process of removing cancer cells by using high intensity x-rays. These high energy x-rays are aimed at the ovarian tumor to destroy the cancer cells .This process also causes damage to the normal cells for its side effects.

There are two types of radiotherapy treatments they are.
â?¢ External radiations: External radiation process is carried out from outside the body. The powerful x-ray beams are aimed at the effected area from outside the body. This process destroys the cancer causing cells permanently.

â?¢ Internal radiations: X-ray beams are passed into the body by making some small incisions in the endometruim area. This treatment gives better results than the external radiation therapy.

Chemotherapy: Chemotherapy is one of the treatments useful in killing ovarian cancer causing cells by the usage of drugs. This treatment process is carried by either pills or through intravascular injections. This anti-cancer drug enters into the bloodstream and travels towards the damaged tissues and destroys the cancer cells.

Chemotherapeutic drugs attacks the cancer cells by stopping their unusual growth. This nature of this cancer cells were brought to the normal condition by controlling the divisibility of the cells.

The chemotherapy drugs are given in the following form:
â?¢ In tablet or pill form(oral)
â?¢ By taking injection(Intravenous or intramuscular)
â?¢ Injection taking in the (Intrathecal)
â?¢ Injection directly in the abdomen vein.

This cancer chemotherapy drug can be given at either clinic or at home. The usage of this drug can be daily, weekly or monthly depending on the stage of the cancer and body immune system. Chemotherapy treatment is given by considering the following basis like age, gender, drug toxicity and body weight. The dosage and usability should be carried under proper supervision.

Ovarian cancer occurs due to unusual growth of cancer cells. This cancer is referred as metastatic cancer for its effects and causes. This cancer also causes endometrial and colon cancer. This cancer can be cured only in the early stage of its occurrence. Surgery and anti-cancer drugs will be useful in treating this ovarian cancer.

Recent cases on headline news about liver metastasis such as Tony Snow’s recent diagnosis derived from his primary colon cancer, underscores the fact that liver metastasis is a major threat to cancer survivors. Although cancer rarely begins in the liver, it is often one of the first places where cancer comes back, through metastasis, in cancer survivors. This is primarily due to the liver serving as a primary organ with a very rich blood supply along with a unique microstructure that allows cancer cells to easily enter and hold on once arriving.

“In fact, about 80% of cancers in the liver derive from primary tumors at other sites within the body,” said Dr. Sujuan Ba, the Chief Science Officer at the National Foundation for Cancer Research (NFCR). Metastatic liver cancers mainly come from primary tumors in the colon, rectum, stomach, pancreas, ovary, breast and lung. When a liver cancer is the result of spreading from colon cancer, the prognosis is usually not optimistic: 5-year survival rates may plummet to as low as 10%.

Treatment of liver metastasis varies depending on the site of the original cancer, the extent of cancer spread to the liver and many other factors. If the metastatic cancer is restricted to one or a few discrete areas within the liver, surgical removal may provide a cure. In other cases, chemotherapy is often used and may produce a therapeutic response in 20% of liver cancer patients. In most cases however, the disease is currently not curable.

Researchers at NFCR believe that with the advancement of technology and ever-growing knowledge about this disease, major improvements in the treatment of colon and metastatic liver cancer are within reach.

NFCR is currently supporting multiple research projects that are aimed at providing hope against liver metastasis by targeting both the primary cancers and their metastasis. NFCR scientists I. Bernard Weinstein, M.D., at Columbia University, Rakesh Jain, Ph.D., at Massachusetts General Hospital, and Wei Zhang, Ph.D., at M.D. Anderson Cancer Center, are exploring alternative routes to tackling primary colorectal cancer cells more effectively. This reduces the cancer cells chances of spreading to the liver and other vital organs. Their research has led to the identification of novel molecular targets, new biomarkers and more potent therapies for the treatment of primary colorectal cancer.

It is much more difficult to treat cancer after metastasis occurs. The good news is scientists at NFCR Center for Metastasis Research may have found some clues against the stealthy spread of cancer. Led by Center Director Danny Welch, Ph.D., researchers at this NFCR Center have discovered several “metastasis suppressors” that prevent cancer cells from growing in the distant sites of the body after they arrive. Metastasis suppressors have been shown to inhibit the spread of breast, prostate, ovarian cancers and melanoma (skin cancer).

About the National Foundation for Cancer Research

Since 1973, the National Foundation for Cancer Research (NFCR) has spent over 0 million funding basic science cancer research and public education relating to the prevention, treatment and cure of cancer. NFCR is about accelerating the pace of discovery from bench to bedside and to educating the public so that, together, we can achieve one of medicine’s greatest goals: curing cancer. For more visit www.liver-health.tk

Incoming search terms:

• colon cancer metastasis lung 2011 2012

XYZ-Wellbeing ReTreat Facility are the only people who have experience in this IV Therapy. It is wrong and can be dangerous to do this therapy with-out a skilled person assisting you. These above specialists have the benefits of my many 40 years experience in the field of Cancer and specializing with what I believe is the best, High PH therapy.

DrPablo at a new clinic opening early in 2009 www.XYZ-Wellbeing.com Dr Pablo heads up the team in a new six year Cancer Trial On Alternative Treatments in Combination. They run for the FIRST 21 DAYS of each month commencing with a weekend workshop the first Saturday of each month. This is a holistic combination that will give you the best possible outcome using these therapies.

Stage 1 has a detoxing and strengthening preparation program for 21 days, & Ozone. Stage 2 Followed by Dr Sartori Ozone and High PH Program month 2 over 21 days. Stage 3 A Recharge and rebuild program that included very high Vitamin C, Hyperbaric Oxygen, Colonic Irrigation, Immune stimulants, just to name a few of the services.

With a relaxing pampering week in between with organic food, massage and many qualified Alternative Practitioners and supportive staff, this clinic is unique.

The programs at XYZ-Wellbeing.com include Ozone, Vitamin B17, also referred to as laetrile, Enzyme Therapy, Vit C for Cancer & Detoxing and or wellness enhancement programs every day, as well as mind therapy and meditation.

Please read all of the Dr Sartori Papers
and only use this program with a supportive practitioner as like all therapies,
side effects can be dangerous,
for example: you can even drown with to much water.
These minerals, Ozone and the holistic approach, when combined carefully
using Dr Sartori s formula, is safe.
However in the wrong combination or hands can be dangerous.

Part 1 HOW TO TURN CANCER INTO A NEW LEASE ON LIFE

 I am proud to announce that the Enhanced High-pH Therapy of Cancer
originally conceived by the world-famous bio and nuclear physicist 
A. Keith Brewer, Ph. D. and
enhanced by the undersigned
is once again available through www.XYZ-Wellbeing.com ReTreat Facility

 
This cancer therapy is based on Natures way of getting rid of cancer. It simulates the life condition of the longevity populations of this world, all of which seem to have many factors in common. These people, many of which live well over 120 years in excellent health, are almost exclusively found in high altitudes of 2000 m (7000 ft) and above. They breathe clean air enriched with tiny amounts of ozone. They drink pure mountain water that flows right of the glaciers. They grow their own food that is rich in vitamins and minerals. Their stress level is low and they are in harmony with their environment.
 
Their spiritual beliefs demand from them to respect all other living beings. It is interesting to note that of the three people with the greatest longevity, two – the Hunzas in Northern Pakistan, and the Abkhazians in the Caucasian Mountains of Georgia near the Black Sea – are devout Muslims, the third, in Vilcabamba, Ecuador, mostly follow Native American Indian animistic beliefs.The first unusual ingredient of the environment of the longevity population – ozone is highly activated oxygen consisting of three atoms. This triatomic oxygen is the most powerful purifier of the Earth and of all living beings. In the simplest terms, ozone is capable of burning all poisonous substances at temperatures between 10 to 40 degrees Celsius (50 to 104 degrees Fahrenheit), as well as killing all bacteria, viruses, and other microorganisms that may contribute to cancers.
 
Ozone is produced by the action of ultraviolet sun light on the oxygen in the air. The higher up we go, the more ultraviolet, and thus, the more ozone. Since time immemorial, it was known that women, who grew up in lowlands, would not get pregnant for at least six months if they moved to altitudes of 3600 m (12000 ft.) or higher. We believe now that ozone naturally prevents a pregnancy until these women are fully acclimatized to high altitudes. In the same way, as ozone temporarily stops the growth of the embryo, it also stops the growth of any fast growing cancer.
We know from the research of Prof. Dr. Otto von Warburg in the 1920s that the cancer cell acts like a plant cell and is dependent for its energy metabolism on lactic fermentation. Fermentation is 19 times less effective than oxidation, the normal energy metabolism of the entire animal kingdom. Fermentation is very sensitive to minute amounts of ozone and there are virtually no cancers observed in people living in altitudes above 2100 m (7000 ft.).
 
All longevity populations live on a diet rich in certain vitamins and minerals that have been proven effective in preventing cancer. Most important among these nutrients are vitamin C (ascorbic acid and ascorbates), vitamin A (retinoic acid and derivatives) and beta-carotene, vitamin E (mixed tocopherols), vitamin D2 from UV irradiation of ergosterol, the high-pH minerals cesium (Cs), rubidium (Rb), and potassium (K), and the trace minerals zinc (Zn), selenium (Se), molybdenum (Mo), and vanadium (V). These nutrients are found in the home-grown vegetables and fruits that are mostly eaten within a few hours after they are harvested. Needless to say, they are grown organically, without the use of harsh chemical fertilizers and pesticides. Most of the drinking water is glacier run-off, called milk of the mountains that is rich in rubidium and cesium. Magnesium (Mg), with calcium (Ca), essential for the transport of oxygen into cells, and potassium (K) with Mg, the most important intracellular electrolytes, are abundant both in green vegetables and drinking water consumed by longevity populations. It is interesting to note that most longevity populations go through prolonged periods of fasts on a yearly basis, be it during the month of Ramadan or during the leaner part of the year before the crops are harvested.
 
If ozone in higher doses is applied intravenously, it is effective not only to prevent cancer, but to reverse many cancers, especially cancers of the lungs, liver, pancreas, and metastatic cancers to the bone, as is well documented in the medical literature. Doctor A.K. Brewerâs high-pH therapy, using high doses of cesium (or rubidium), and enhanced by weak acids such as ascorbic acid (vitamin C) and retinoic acid (derived from vitamin A) , as well as ampholytic elements such as zinc and selenium, has been proven effective in virtually all fast growing cancers, both after oral and intravenous application. This is further enhanced by amilonitriles contained in apricot pits that are part of the regular diet of the Hunzas, and may also be applied intravenously in the form of Laetrile.
 
The intravenous form of the enhanced high-pH therapy also contains generous amounts of the intracellular electrolytes magnesium and potassium. The dosage of the I.V. therapy is adjusted to reduce virtually all smaller cancer accumulations (up to 20 or 30 cm diameter), providing that they are fast growing tumors, by one to two centimeters per day (2/5 to 4/5 per day). Large tumor masses are reduced with the I.V. therapy by 500 to 900 grams per day (1 to 2 lbs. /day) to prevent an over-loading of the bodies metabolism and excretion with tumor breakdown products. The critical factor is the kidney and liver function of the cancer patient before the enhanced high-pH therapy is started. One important thing to keep in kind is that, though the enhanced high-pH therapy was seemingly effective, some patients may still succumb from the adverse effects of cancer chemotherapy, or from complications of radiation or surgery undergone previously. Also, if a cancer patient, after the tumor disappeared with the high pH therapy, does not change his lifestyle and eating habits, cancers may develop again in h
is or her body.
 
How does all of this work?
Most orthodox cancer chemotherapy proffers only a large number of unproven theories and in almost all cases shortens the survival after severe suffering form its adverse effects1. On the other hand, the enhanced high-pH cancer therapy is proven effective by clinical and experimental studies that filled over two thirds of Supplement 1, to the major peer-reviewed medical journal Pharmacology, Biochemistry, and Behavior, of December 1984 [21 Suppl 1: 1-135]2.
 
Also, on this therapy, almost all patients, no matter how far gone or suffering from the adverse effects of chemotherapy and/or radiation, will feel much better within a few days. Particularly, cancer pain, even if unresponsive to the most powerful pain killers, in most cases disappears within only a few hours after starting the cesium.
 
Any symptoms connected with this therapy, particularly from the I.V. ozone, are almost always the result of a healing crisis, well known to homeopaths for over 200 years. These symptoms may be quite uncomfortable but subside in most cases within a few hours, and many patients report that afterwards they felt better then ever before in their lives.
 
1 See Appendix II to the author’s two Cancer Articles: “Nutrients & Cancer” and “Cesium Therapy in Cancer Patients”, Pharmacol Biochem Behav 1984; Suppl 1: 7-10 & 11-3, respectively.
 
2 See Appendix I to and also the author’s two Cancer Articles of 1984.
 
In the following we will briefly explain how cancers form (i.e., carcinogenesis) and how the enhanced high-pH cancer therapy transforms cancer cells either to normal cells or makes them disappear altogether.
 
Professor Dr. Otto von Warburg, double Nobel laureate, in medicine and biochemistry, in the 1920s discovered the fundamental mechanism of carcinogenesis. When certain cancer-causing chemicals (carcinogens) attach to the cell membrane, the oxygen carriers calcium and magnesium are unable to enter these cells. The resulting oxygen starvation causes these cells to regress to anaerobic (i.e., without oxygen) metabolism [which is 19 times less effective than aerobic (with oxygen) metabolism, as was stated previously].
 
The end product of anaerobic breakdown of glucose is lactic acid which renders the cell acidic. This acidosis, in turn, causes the genetic changes that result in the uncontrolled growth of cancer cells. The pH in cancer cells, because of the lactic acid buildup, lowers from about 7.2 to 7.0 (in fast growing tissues) to between 6.8 and 6.0, and in some fast growing metastases to even 5.5. This renders cancer cells extremely vulnerable to ozone and alkalinity which, if applied in minute amounts, either normalizes or destroys them.
 
Specifically, intravenous ozone has the four major effects in cancer patients.
 
One, it removes homeopathically whatever disposed a specific organism to cancer and this causes the healing crisis. This healing crisis may be quite uncomfortable subjectively (though lasting at most a few hours), but there is less than a one in a million chance of serious complications.
Two, ozone removes all toxic and carcinogenic chemicals, amoebas, viruses, bacteria, and other agents from the body that may in some way contribute to cancer and this may be the reason why it seems to be cancer preventative.
Three, ozone inhibits any fast and uncontrolled growth typical for cancer cells.
And four, ozone has a well documented immuno-stimulating effect that helps both with the protection from cancer and with the removal of cancer cells destroyed by the high-pH therapy, enhances the body’s resistance to infections, and boosts longevity.
The more acidic the cancer cells, i.e., the lower their pH, the more vulnerable they are to alkaline, or high-pH, agents. While normal cells are not permeable for cesium or rubidium, and require a transport mechanism for potassium, these three alkalizing elements freely diffuse into cancer cells. This causes the pH to raise in cancer cell; and the higher the pH in the cancer cells, the faster the cancer breaks down. If the intracellular pH is raised to above 8.5, you can actually see the skin wrinkle while you watch over areas where there previously was a superficial cancer tumor, e.g., a breast cancer.
 
This diffusion of alkalizing elements is enhanced by ascorbic acid (vitamin C) and retinoic acid (from vitamin A). Zinc and selenium further enhance the penetration of cesium, etc., by broadening the electron donor capacity of the cell membrane. Zinc and selenium are also powerful immunostimulants, and help with the removal of tumor cells by phagocytotic (lit. cell-eating) neutrophil leukocytes (white blood cells) and monocytes (also called macrophages or â big cell-eaters). Selenium, vitamin E, and beta-carotene are powerful antioxidantts that scavenge dangerous free radicals. Vitamin E also prevents the toxicity of high doses of vitamin A. Molybdenum enhances cancer-destroying oxidases, and vanadium assists with lipid and fatty aid metabolism for faster breakdown of cancers.
 
What is the reality of the 2004 State of the Cancer Treatment in the U.S.A.?
After 35 years of war-on-cancer, and almost $ 90 billion of research funding by the U.S. Government, the cancer death rate in the U.S. of A. increased almost six-fold from 145,000 in 1970, to an estimated 850,000 for 2004. Each insured cancer patient is presently worth between $ 150,000 to $ 500,000 (average about $ 200,000) to the medical profession, hospitals, and the pharmaceutical industry. The out of pocket expenses for insured patients range from $ 30,000 to 100,000, average about $ 40,000, whereas the ULS Cancer Therapy is offered at $ 16,000.00 / €14,000.00. The total national expenditure for cancer management to the premature death of over 800,000 people per year exceeds $ 100,000,000 ($ 100 billion), and, in addition, there are economic losses of the families of the prematurely deceased of perhaps $ 120 billion if their lives had been saved by effective alternative therapies.
 
This total financial investment for patients undergoing the enhanced high-pH cancer therapy is about one-half to one-tenth of the out of pocket expenses of the average insured cancer victim undergoing conventional orthodox cancer therapies. Best of all, the success rate with the enhanced high-pH therapy is consistently much higher and in many cases over 95%, particularly if you are not suffering from severe toxicity of chemotherapy or from radiation damages. And this includes proven incurable (i.e., by orthodox therapies) cancers of the lungs, liver, pancreas, brain, prostate, breast, bones, melanomas, lymphomas, sarcomas, and leukemias.
 
Because of the potential (especially, financial) impact of the enhanced high-pH therapy on the medical/hospital/pharmaceutical industry complex and their most powerful lobby in Washington, D.C., and in many State Governments, this effective, economical, non-toxic treatment can only be offered offshore, i.e., at a location outside the United States. However, every effort is made to have these offshore hospitals properly accredited and to have the costs of the treatments reimbursed by most insurance carriers. The first of these locations is now available in Northern Thailand at a first class hospital for Alternative Medicines that, Insha’Allah, will be upgraded to the point that it is eligible for Blue Cross insurance payments. (Added update) and also at XYZ Wellbeing ReTreat Facility and Research Cancer Centre in  Located in the the beautiful  Cartagena South America. Visit www.xyz-wellbeing.com and go to the why choose us link for more cesium information and cancer research.
 
Therefore, if you, or any of your loved-ones or friends have cancer, even if it was so far ân incurable with chemo, radiation, and/or surgery, please contact The above to see if you may be eligible for the enhanced high-pH therapy. We are committed to one thing only ând to return yo
u to your mental, emotional, and spiritual wellbeing. As long as you faithfully follow the path that we map out for you, you have an excellent chance of emulating the joyous, vigorous longevity of the people who served as the models for the enhanced high-pH therapy. However, it cannot be stressed enough, that the shrinking of a tumor is by far the lesser part of overcoming cancer.
 
Much more important for lasting success is to overcome the cancer personality, defined in the 1960s by Lawrence LeShan, and to embark on an overall healthy lifestyle that equals and excels (by more advanced knowledge) the one the longevity populations. And, perhaps, most important is your will to live and your absolute need to have to accomplish things that must not be left undone by your premature death from cancer. By taking charge of your life in this manner and by taking responsibility by following our leads in all aspects of your life, you will make it possible not only to become free of cancer but remain free of it permanently.

We can only lead you to the Path.
 
It is up to you to walk it and to make sure that everyone around you walks it with you and all the way!

No matter what, always keep in kind that, fundamentally, the Lord wills the ultimate outcome of everything in your life. Just as the Lord lead you to the enhanced high-pH therapy to get rid of your cancer tumor, and to the comprehensive Ultralifescience Program for physical, mental, emotional, and spiritual wellbeing, the extent to which you will succeed with it is entirely as the Lord wills. Our promise to you is simply that we will leave no stone unturned to provide for you all the tools for your success in this endeavor.

To your abiding health, vigor, and happiness!

__________________________________

Abdul-Haqq H.E. Sartori, M.D.

NOW THAT YOU HAVE LEARNED THAT YOU HAVE TERMINAL / INCURABLE CANCER

Cancer is perhaps the most feared disease on Earth since more and more people find out that the treatments offered for it in modern hospitals – surgery, radiation, and chemotherapy – seem to help only a small percentage of people who, in most cases, suffer from crippling mutilations and burns (from surgery and radiation), or severe, often life threatening, side effects from the poisonous chemicals used for chemotherapy.
 
Don’t despair! There is still hope for you!
 

Even if your doctor sends you home to die perhaps telling you “We have done everything we know, there is nothing else we have to offer to help you, except letting you die in peace”.

Did you ever wonder that before about 1900, cancer was a rare disease and that in some parts of the world there is NO CANCER at all? Research that goes back to Dr Otto von Warburg in the 1920s revealed the true nature of cancer and Dr A. Keith Brewer since the 1950, in part through investigation of cancer-free populations, formulated an effective treatment for cancer. This treatment was applied to many cancer patients and further enhanced by Dr Sartori since1980.

Almost all cancers in over 700 patients treated so far with this enhanced high pH therapy, responded within a few days and with I.V. application, daily shrinking of tumors between 1.0 and 2.0 cm can be expected. The only discomfort from this treatment comes from a “healing crisis” reaction that leaves you, after some initial discomfort, feeling better after a few hours or, at most, a day or two. How does this all work? Dr von Warburg found that cancer cells, like plant cells, function without oxygen and thus are very sensitive to oxygen and very strong alkaline elements. Because of the lack of oxygen, cancer cells break down their fuel, glucose, to lactic acid. This causes cancer cells to become acidic (i.e., the pH in the cancer cell is lowered to 6.8, even 5.8) which, in turn, causes them to grow out of control. Alkaline elements, particularly cesium, but also rubidium and potassium can freely enter cancer cells (but not normal cells) causing them to become alkaline or raise the pH in the cancer cell. This raised pH slows down the cancer growth and at a pH of 8.0 all cancer cell growth stops and the cancer cells either die or are turned into normal cells. While we all depend on oxygen to survive, cancer cells die if exposed to oxygen and, particularly, its most powerful form, ozone. People who live very long are free of cancer, is a fact that prompted Dr Brewer to investigate their nutrition and found that their diet contains the alkaline elements cesium (Cs), rubidium (Rb), and potassium (K), and other nutrients that were found to reduce the cancer incidence such as zinc (Zn), selenium (Se), molybdenum (Mo), vanadium (V), and the vitamins A, C and E, as well as amygdalins from apricot pits. After extensive studies of cancer cell cultures, Dr Brewer found the following: Zinc and selenium attach to the cancer cell membrane and make it easier for the cesium and rubidium to enter the cancer cells. Vitamins A and C are weak acids that attract these elements to the inside of cancer cells. Magnesium (Mg) and calcium (Ca) that normally transport the oxygen into cells are depleted in cancer cells. These and other findings were the basis for Dr Brewer to formulate the high pH therapy for cancer. His method was enhanced in the 1980s by adding I.V. ozone (which is the most active form of oxygen), herbal combinations, and other modalities, which made it even more effective.

Up to 98% of animals with cancers were cured by Dr Brewer’s high pH therapy.

Tests on mice fed cesium and rubidium showed marked shrinkage in the tumor masses of abdominal implants of mammary tumors (“breast cancers”) within 2 weeks. In addition, the mice showed none of the side effects of cancer. Cesium chloride, zinc gluconate and vitamin A were used together to alter growth of colon cancer implants in mice and the use of these compounds was responsible for the disappearance of tumors in 98% of the animals. Sarcoma I implants in mice and Novikoff hepatoma in rats disappeared if the proper ratio between cesium and potassium was maintained. With Dr Brewer’s complete protocol, using cesium (&/or rubidium), potassium & magnesium, vitamins A, C, & E, zinc, selenium, & amygdaline, there was a prompt reduction of all tumors treated by Dr Sartori including lymphomas in cats and dogs, skin cancers in dogs, cancers of the mammary glands, mouth , and esophagus in horses, and cancers of unknown primary in chickens.

Like with all “nutritional” treatments, the principle of the weakest link of the chain holds true, and if even one essential nutrient is lacking, the treatment may fail. In virtually all of over 700 patients with different types of cancer, the enhanced high pH therapy was effective in reducing the tumor mass. Over 90% of these patients were terminal with extensive metastasis and had received maximum conventional cancer treatments. Malignancies treated with this protocol included cancers of the lungs, liver (& gallbladder), pancreas, breast, prostate, colon & rectum, stomach, brain, cervix & uterus, ovaries, testicles, adrenals, kidneys & bladder, of unknown primary, rectovaginal, etc., as well as lymphomas & leukemias, melanomas, & sarcomas & bone. The results with the LSU/ULS Cancer treatment in 100 cancers are detailed in the attached articles. Summary of and Comments on the LSU (now ULS) Cancer Treatment Results. There are several factors that should be pointed out with regard to the data summarized in Table I

(a) Out of over 500 cancer patients treated from 1980 to 1987, only 97 fulfilled the criteria of having been followed up for at least 5 years or until their death. This might negatively bias the number of patients that have died by a factor of up to five since almost all of the over 500 patients were followed for at least 3 months.

(b) According to Arlin J. Brown (AJB), cancer survival statistics as published by the National Cancer Institute (NCI) are not point-to-point, but are determin
ed from the number that can be located 5 years after being diagnosed with cancer (and not even the beginning their first treatment, e.g., at) at NIH/NCI. In cancers with high mortality such as small cell lung cancers (1.0% 5-year survival according to NCI) and pancreas cancers (3.0% 5-year survival according to NCI), AJB found point-to-point survival rates of less than 0.01% and less than 0.05% respectively (perhaps because >99% of the patients had died so long ago that they could not be located anymore).

(c) By far, the majority of the patients seem at LSU were using our therapy as their last resort after all other treatments (both conventional & alternative) had been unsuccessful and most patients were simply sent home to die.

(d) In view of the extremely unfavorable patient population as outlined under (a) through (c), we believe that the results of the LSU treatment are quite remarkable and by far the best offered anywhere in the world.

(e) For reasons beyond the control of the authors, only about 200 cancer patients were treated from 1988 through 2003. In all of these patients, ozone and the minerals and vitamins were applied intravenously (I.V.). The I.V. application of minerals and vitamins proved to be a dramatic improvement in that (i) in virtually all cases, the size/diameter of all fastgrowing tumors was reduced by 1.0 to 2.0 cm (0.4 to 0.8 inches) per day, i.e., a disappearance of a 5.0 cm (2 inch) tumor within four days and of a 10 cm (4 inch) tumor within eight days, and (ii) virtually none of the patients showed any of the side effects frequently encountered with oral vitamin/mineral application such as nausea, diarrhea, abdominal discomfort, possible aggravation of ulcer symptoms, and sometimes even vomiting.

After several cancer patients were successfully treated at the Integrated Medical Center in Northern Virginia from April to July 1998, from mid 1998 until mid2003, government agencies and law enforcement in the U.S.A. virtually completely suppressed the use of the enhanced high–pH cancer therapy by LSU/ULS, and this treatment can now only be offered offshore and far removed from these agencies.

RESULTS WITH THE LSU/ULS TREATMENT PROGRAM FOR CANCER

(broken down into the most frequent types/locations of cancers treated) 1. Lung Cancers Of the 18 lung cancers described in this study (of a total of >100), 14 were connected to active smoking, two to passive smoking, one to radon exposure in the home, and one to cadmium exposure at the workplace. Asbestos may have been a factor in one of the active smokers, radon in the home in one of the passive smokers.

Beta-carotene, vitamin A, selenium, and vitamin E from green and yellow vegetables are now recognized as clearly preventative of lung cancer. These vegetables were conspicuously absent from the diet of most of our lung cancer patients. Instead, most of them were eating a meat and potato diet before they started the LSU cancer treatment program. Histologically, 4 patients had epidermoid cancers, 3 had adenocarcinomas, 8 had small cell carcinomas, 2 had large cell carcinomas, and in 2 patients the histologic type was unknown; two of the small cell carcinoma patients also had a lymphoma. All patients had received the full course of orthodox treatment: 6 had surgical resections (3 of the epidermoid-, and one each of the adeno-, small cell-, and large cell carcinomas). All patients had received chemotherapy, and the 6 surgical patients also had received radiation. At the beginning of the treatment, four of the patients were dying on a stretcher, four could walk only with assistance, six were given a prognosis of less than 6 months of survival, and in 4, the prognosis was unknown. The 2 patients with unknown histology who came in dying on a stretcher nevertheless survived 13 and 20 days respectively. The third of the dying patients, with an epidermoid cancer, survived almost 3 months until he died from internal bleeding from an extremely low platelet count. The fourth of the dying patients survived over 5 years and was well in July 1992; he had a small cell carcinoma that generally has less than 1% chance of 5 year survival (less than 0.01% according to Arlin J. Brown). One of the two small cell carcinoma patients who also had a lymphoma is alive and well without any sign of cancer over 10 years after he was barely able to walk into the office with assistance. He is now in excellent health and successfully runs a medical equipment company. The other unfortunately died in a hit-and-run car accident 10 months beyond his given life expectancy and without any sign of cancer at autopsy. One of the adenocarcinoma patients who came in, walking with assistance, responded well for about 2 weeks, then continuously deteriorated, and died after 4 months. The fourth walk-assist patient, with a large cell cancer was treated 4 times and died after 1 year and 8 months. Of the 6 patients who were given fewer than 6 months to live, one epidermoid cancer patient died from cardiac failure after 3 years and 4 months, one of the small cell cancer patients with terminal emphysema died from a combination of pulmonary failure and bronchopneumonia; one patient with adenocarcinoma received 6 treatment series and died from his cancer after 3 years and 8 months; one small cell cancer patient died after 2 years 5 months, one after 4 years 1 month, one epidermoid cancer patient died after 3 years 3 months. One of the factors in the deaths of these patients may have been that at the time of their treatments, the LSU mental reconditioning program (MRP) was far less developed. By using the full, presently available LSU MRP, perhaps at least two, maybe even four of these patients could have been helped. Of the lung cancer patients who survived over five years, four had a small cell cancer, one had a large cell, and one had an epidermoid cancer. 2. Lymphomas Of the 13 lymphomas described in this study (of a total of >60), 9 were lymphocytic (3 males had AIDS, one male had severe rheumatoid arthritis, and one was a Klinefelter syndrome; 4 were females), one female had Hodgkin lymphoma, one male had a T-cell lymphoma, and in 2 males, the histology was not determined. Three patients were dying, 4 needed ambulatory assistance partially because of their enormous tumors, and 3 were given less than a year to live. One of the dying patients with lymphoma of unknown histology died after 17 days from cardiac toxicity of chemotherapy. Another of them, an AIDS patient, died after 7 weeks from aplastic anemia from combined chemotherapies for infections and the lymphoma, given to the patient prior to his coming to LSU. No signs of lymphoma were detected at time of death. One 37 year old dying woman has survived over 10 years without any sign of recurrence after only one series of the LSU treatment.

Of the 4 patients who needed assistance with walking, one AIDS patient is alive and well for over 8 years, has turned HIV negative at the end of one treatment series and his T4 cell count rose from 124 with a T4/T8 ratio of 0.36 to between 1,100 and 1,300 with a T4/T8 ratio between 1.5 and 1.8 for the last 4 years. Within one month, his nodal lymphomas disappeared and none of his previous CNS involvement was detected anymore on a CAT scan. One patient had a huge hemispheric protrusion of his abdomen, very similar to a patient described in Pharmacol. Biochem. Behav., Vol. 21, Suppl. 1, pp. 11-13, 1984. His total tumor mass was estimated to be about 37 kg with about 40 liters of ascites. Within 3 weeks both tumor and ascites were reduced to approximately one half, within 2 months there was only a slight enlargement of the spleen of about 5 cm. The patient survived for over five years without any sign of tumor recurrence. The two patients who had both lymphoma and lung cancer were already discussed under 1.; one of them is alive and well, the other died 10 months after treatment in a hitand- run accident. He had shown no signs of cancer at autopsy. One of the 3 patients who were given less than a year to live, unexpectedly died from a heart attack
10 months after initial treatment. Another died after 3 years and 7 months and did not respond to treatments, except for the initial series. The third patient survived for over 5 years without sign of tumor recurrence. The woman with Hodgkin lymphoma died from aplastic anemia, a complication of her previously received chemotherapy, 1 year and 2 months after treatment onset. The patient with the T-cell lymphoma had come all the way from Osaka, Japan and seemed to respond well to the first treatment series. He returned 5 months later, showed barely any response to the treatment, and died 11 months after the initial visit. Language problems may have been a contributing factor to his death, since we were not sure, whether he and his family had completely understood our instructions. 3. Liver Cancers Primary hepatocellular carcinoma (HCC) or malignant hepatoma is one of the most common malignancies in the world and it is estimated to be responsible for up to 1,300,000 deaths every year. In portions of Africa and Asia, HCC is the most common malignant tumor. It occurs infrequently in the U.S., North and South America, and Europe where it accounts for about 2% of the malignancies. The incidence of HCC is especially high in China, Taiwan, Mozambique, and Singapore. Risk factors of HCC include chronic toxic hepatic injury (20 to 60% in N&S America), cirrhosis (60 to 90% worldwide), chronic hepatitis B infection (20 to 90% worldwide), aflatoxin (especially in Africa and Asia, e.g. from peanut oil), alcoholism, chronic hepatic outflow obstruction (CHOO; 20% in South Africa, 60+% in Japan), male gender (5:1 in high incidence areas, 2:1 in low incidence areas), Asian or Black ancestry (or rather dietary habits). Of the 12 patients listed as having liver cancer (of a total of >50), 8 had primary HCC, 3 had extensive liver metastasis from an occult primary malignancy (OPM), and one patient had intrahepatic biliary cancer (IHBC).The 8 patients with HCC had elevated alpha fetoprotein (AFP) and reduction of AFP below 100 mg/mL was interpreted as an indication of tumor disappearance. Using a cutoff for serum levels of 10 ng/mL, AFP is sensitive for HCC in 70 to 90%. Patients with cirrhosis and chronic hepatitis tend to have elevated AFP levels of usually under 200 ng/mL. Levels of 400 to 1,000 ng/mL are diagnostic for HCC. AFP is also elevated in yolk sac tumors and in a high proportion of other germ cell tumors.

The patient with IHBC and the 3 patients with liver metastasis from OPM had elevated carcinoembryonic antigen (CEA) in the range of 55 to 185 ng/mL at their admission to the LSU cancer treatment program. No colorectal cancer or other primary malignancy was ever found. Elevated CEA levels are found in patients with gastrointestinal, pancreatic, breast, lung, thyroid medullary, and genitourinary carcinomas, as well as in benign disorders including inflammatory bowel disease, cirrhosis of the liver, pancreatitis, and pneumonia. Normal values for CEA are up to 2.5 ng/mL, in smokers up to 5.0 ng/mL. Benign disorders seldom elevate the CEA level above 10 ng/mL. Reduction of CEA levels below 5 ng/mL was interpreted as an indication of tumor disappearance. Of the 12 liver cancer patients, 3 were dying, 3 needed assistance when walking, and 4 were given life expectancies of less than 6 months. 9 had undergone surgery, including the 3 OPM and the IHBC patients; 5 had suffered radiation treatment, and all 12 had been exposed no massive chemotherapy. One female HCC patient, a 32-year-old fitness instructor, had been first seen in the office of a world famous diet doctor in New York City, where she almost died on the table from an imbalanced vitamin-mineral IV. Through almost a miracle she made it to Washington, D.C., lying on a stretcher in the station wagon driven by her husband. Within 2 weeks her massively enlarged liver that had extended over 14 cm below the normal in a scalloped curve that filled about two-thirds of her abdomen, had returned to normal. Her AFP test came down from 2,420 ng/L to 120 ng/mL within 24 weeks. She was well until about 4 years later when she died in a car crash. Unfortunately, the diet doctor never referred any other cancer patient to the LSU clinics. Four more of the HCC patients, and one of the OPM patients, responded very well and survived over 8 years after their initial treatment without signs of recurrence, with AFP and CEA below the cutoff points of 100 ng/mL and 5.0 ng/mL respectively. One HCC patient died from the side effects of chemotherapy within 2 weeks, another within 2 months; one OPM patient shared the same fate after fewer than 3 months. The IHCP survived 2 years and 4 months, after responding moderately well to 3 courses of the LSU cancer treatment. 4. Pancreas Cancer The tumor-associated carbohydrate antigen, CA 19-9, detects about 80% of all pancreatic cancers correctly, compared with 8% of patients with pancreatitis and 1% false positive normal patients. The pancreatic adenocarcinoma glycoprotein, DU-PAN-2,. detects up to 55% of all pancreatic cancers, though in may also be elevated in patients with biliary cirrhosis, gastric cancer, and biliary cancer. In all of our 11 pancreatic cancer patients(of a total of >50), either CA 19-9, DU-PAN-2, or both markers were elevated to a range of 850 to 950 U/mL for CA 19-9, and 300 to 1,200 U/mL for DU-PAN-2 at admission, and reductions of serum levels below 70 or 120 U/mL, respectively, were considered as evidence of disappearance of the tumor. CA 19-9 antigen (detectable by a murine IgG1 monoclonal antibody against a human colon carcinoma cell line) is elevated in 55 to 90% of stomach cancers, 80% of pancreatic cancers, and about 95% of colorectal cancers; in advanced pancreatic cancers it is elevated in 80-90%. In benign disorders including acute pancreatic, hepatobiliary disease, and inflammatory bowel disease, CA 19-9 usually does not exceed 100 U/mL. Normal values of CA 19-9 are up to 36 U/mL. DU-PAN-2 is a mucin-type glycoprotein antigen selected for reactivity against human pancreatic carcinoma cells (detectable by murine monoclomal antibodies). Increased levels occur in many diseases of the liver and hepatobiliary tree including primary biliary cirrhosis, sclerosing cholangitis, hepatitis, cirrhosis, and benign hepatomas, and usually do not exceed 200 U/mL. DU-PAN-2 may also be elevated in biliary and gastric cancer, and in primary hepatocellular carcinoma (HCC). Normal DU-PAN-2 values are up to 60 U/mL. Histologically 10 of the 11 patients had an adenocarcinoma of the pancreas, one had an intrapancreatic bile duct carcinoma (IPDC) that was diagnosed intraoperatively. One patient had both stomach and pancreatic cancer. Eight of the patients had undergone resections and/or exploratory surgery, 10 had suffered from radiation, and all 11 had been given massive doses of chemotherapy.

At the onset of the LSU treatment,
one patient was dying, 3 needed walking assistance, and 6 were given fewer than 6 months to live.

Two patients died from the side effects of chemotherapy within less than 3 weeks including the patient with IPDC. One other succumbed from chemotherapy side effects after 10 weeks. One patient died after about 10 months from an internal bleeding probably not related to cancer. The patient with stomach and pancreatic cancer did not respond well to 3 treatment courses. Nevertheless, they prolonged his life from an expected less than one month to 1 year and 7 months. One patient died after 3 years and 2 months, another after 3 years and 11 months. Nevertheless, the treatment had extended their life expectancy of less than 6 months. Four of the 11 patients survived more than 5 years which compares favorably with a reported 5-year survival rate of pancreas cancer patients of 3% (or less than 0.01% according to Arlin J. Brown). 5. Breast Cancer Six of the nine breast cancer patients (of a total of >40), who are discussed in this report were terminal with widespread metastatic disease, one of them dying, two of them needing walking assistance, and another three with a life expectancy of less than 6 months. In all cases,
any detectable primary tumors or metastatic skin tumors either disappeared within 2 weeks or turned from hard, knobby, scalloped, infiltrative cancerous growths into much smaller well-defined, round, and much softer benign cysts with a smooth surface. Unfortunately, two months after treatment onset, one patient died of cardiac failure from doxorubicin toxicity, and one patient died from acute pericarditis-myocarditis from cyclophosphamide less than 3 weeks after treatment was started. One patient responded well to the first treatment course, but had a recurrence after 3 months, and died from pneumonitis. It is possible that an ill-advised treatment course with bleomycin may have contributed to her demise. One patient, a former heavy smoker aged 57 when her treatment began, died after 2 years and 11 months from a myocardial infarction. 5-fluorouracil treatment may also have contributed to her premature death. Another patient who responded poorly to the treatment nevertheless survived 2 years and 2 months, more than 2 years longer than she expected before she started the LSU treatment. The remaining 4 patients survived over 5 years without any sign of recurrence. 6. Prostate Cancers Six of the 8 prostate cancer patients in this study (of a total of >40), had extensive metastatic disease, one of them was dying, two needed assistance with walking, and 4 were given less than 6 months to live. All patients showed elevated levels of prostatic specific antigen (PSA) that ranged from 35 to 235 ng/mL at admission (Normal PSA < 4.0 ng/mL). In benign prostatic hypertrophy (BPH), PSA levels <25 ng/mL are seen. PSA is false negative in about 15% of the prostate cancers. The cutoff point for the disappearance of the cancer was set at 10 ng/mL. Very similar to the results in breast cancer patients, all palpable infiltrating tumor masses in all patients either disappeared or turned into benign, well-defined, cystic tumors of much smaller size. The dying patient succumbed to the side-effects of his chemotherapy 20 days after the beginning of his treatment. One of the severely debilitated patients died after 9 weeks also as a consequence of his chemotherapy. Two patients only partially responded to the treatment. One of these died in a horseback riding accident, the other died after 4 treatment courses 2 years and 5 months after he started the LSU cancer treatment. He had survived almost 2 years longer than was originally expected.

Four patients survived at least 5 years, two of them needed only one treatment course, one of them needed two, and the fourth needed four treatment courses. Their PSA levels were maintained below 10 ng/mL after their treatments were completed. 7. Colorectal Cancers Of the 6 patients in this study with colorectal cancers (of a total of >50), all had elevated values of carcinoembryonic antigen (CEA) in the range of 80 to 280 ng/mL, indicative of widespread metastatic disease; all of them had undergone surgical resections, 4 with colostomy, and 2 without colostomy. All 6 had received a full course of chemotherapy with 5-fluorouracil (5-FU) and a variety of other chemotherapeutics. Two of the patients received radiation therapy. The response of these patients to the LSU treatment program was not as impressive as for instance, in the case of liver cancer patients. Only the 2 patients without colostomy survived more than five years after 2 and 3 LSU treatment courses respectively. In both cases, the CEA was maintained below 5.0 ng/mL. One of the colostomy patients died from a heart attack after a good initial response to the treatment in the 11th week of his treatment. 5-FU-induced myocardial ischemia may have been a contributing factor. Another of the colostomy patients apparently died from a barbiturate overdose, possibly a suicide attempt. It should be noted that over 35 of the colostomy patients were lost in the follow-up. The two patients who had suffered abdominal radiation had severe problems with adhesions and fistulas. Both had severe diarrhea at admission that was controlled with diet within about 2 to 3 weeks. Though both had a life expectancy of less than 3 months at the time of admission, they survived for 2 years and 7 months, and 3 years and 3 months, respectively. Their CEA levels returned to below 5.0 ng/mL after 3 months and stayed there until their deaths. 8. Uterine Cervical Cancers All 6 patients in this study (of a total of>30) had undergone radical hysterectomies and pelvic lymphadenectomies, multiple radiation treatments, and full courses of chemotherapy (4 patients received a combination of doxorubicin and methotrexate; 4 patients received mitomycine, vincristine, and bleomycin; one patient had been given both combinations). One patient died after 2 years and 20 months after undergoing 4 courses of the LSU treatment. Originally she was given less than 3 months to live. One patient fell down a flight of stars, fractured her neck and died with hours. She had survived 3 years and 5 months. Her original life expectancy was less than one year. Two patients survived 5 years and had no indication of tumor recurrence on CAT scans and NMR imaging. For the normalization of abnormal Papanicolaou (PAP) smears [Group 2: Infections; Group 4: squamous cell CA; Group 5: adenocarcinoma; Group 6: nonepithelial malignancy] and even of Stage O (Carcinoma in situ) through Stage IA2 (strictly confined to cervix; depth: £5 mm, spread: £7 mm), cervical cancers, topical application of folic acid in conjunction with vaginal ozone application has been found virtually 100% effectivein about 30 patients. Vaginal ozone applications are also an effective prevention of cervical cancers since it removes HPV and other pathogens that are causing chronic cervicitis that may turn malignant. 9. Brain Cancers All 4 brain cancer patients (of a total of about 15) had highly malignant extensive glioblastomas. All 4 had undergone surgery and radiation, as well as glucocorticoid therapy. Two of the patients were unconscious at admission. The two conscious patients complained about headaches, especially in the morning, loss of appetite, nausea, loss of concentration, reduced mental capacity, and increased sleepiness. In both, personality changes were clearly evident.

After treatment onset both unconscious patients regained consciousness within 3 days and were able to say simple sentences within 5 and 8 days respectively. One of these patients suddenly deteriorated in the 4th week, possibly from malnutrition. His sister, who supervised his feeding, had failed to properly follow our instructions. When we found out that there was a problem, the patient was already beyond recovery. The other patient recovered well enough to return to his job as a real estate broker, and has survived 5 years without sign of recurrence. Both of the two conscious patients had a lethal car accident; one about 2-1/2 years, the other about 3-1/2 years after their treatments. Both accidents may have been related to personality and psychomotor changes caused by their original tumors. 10. Melanomas The three patients with melanoma in this study (of a total of about 12) all had widespread metastatic disease. They all responded well to the first course of treatment though less favorably to further treatment courses. One of the patients died after 11 months. She had originally been given less than one month to live. Another patient who had been given less than 6 months to live survived 2 years and 10 months. One of the patients, a black woman who had undergone 5 courses of treatment, survived 5 years without sign of malignancy. 11. Other Cancers The number of the 10 remaining tumors in this study (of a total remaining of >80), two ovarian cancers, two stomach cancers (one of which was combined with a pancreatic cancer; see under 4.), one osteosarcoma, one soft tissue sarcoma, two kidney cancers, one bladder cancer, and one adrenal cancer, is too small to allow any clear judgment of the effectiveness of the LSU treatment in these specific cancers. In all cases, a prompt response was seen in the first treatment course. One kidney cancer patient died af
ter 20 days as a consequence of his chemotherapy. The other kidney cancer patient responded moderately well to the LSU treatment and died after 4 years and one month (well over 5 years after his original diagnosis & thus “cured” according to NCI statistics,). The stomach cancer patient who also had pancreas cancer is described above under 4. He died after 1 year and 3 months. The other-stomach cancer patient responded moderately well to consecutive LSU treatments and died after 4 years and 2 months (rather than after less than one year ; & would also be listed by NCI as “cured”). One ovarian cancer patient responded well and survived over 5 years. The other responded moderately well to consecutive LSU treatments and survived 3 years and 10 months.The bladder cancer patient did not respond well and died after 11-1/2 months (rather than after less than 1 month). The adrenal cancer did well, needed only one LSU treatment course, and survived over 5 years without sign of recurrence. Continued next page

The 200 Plus Cancers Treated from 1987 through 2003 The following are only general remarks since on 2 May 1992, U.S Government Agents simultaneously broke into three locations where the originals and two copies of some 3000 patient records treated by LSU from 1980 through 1992, including about 650 cancer patients, about 180 AIDS patients, about 80 multiple sclerosis patients, and over 2000 patients with different conditions that were the data basis for the 2d ed. of the Ozone Book that for reasons beyond the control of the authors took until the year 2004 to be finally completed. . Again, we see a prevalence of “incurable” cancers (a) which have 0.0% success rate and thus should NOT be treated conventionally at all, including, small cell lung, pancreas, & esophagus cancers, acute adult leukemias, and all cancers with widespread metastasis; (b) malignancies where conventional treatment in almost all cases shortens the life span, including, stomach, brain, liver, & most ovarian cancers, multiple myeloma & chronic adult leukemias, as well as large (>10 cm = >2″) fast growing cancers with lymph node metastasis; (c) cancers with the highest incidence (in the USA & Western Europe), including, (female) breast, prostate, lungs[see (a)], & colon, where with early detection there is about 50% 5-year survival in breast, of 60% in prostate, & about 25% in colon cancers, that drops precipitously to some 10% if (b) & 1.0% if (a), supra, conditions are present; (d) other cancers including non-Hodgkin lymphomas, cancers of the urinary bladder & kidneys, rectum, (epi/naso)pharynx & oral cavity, endometrium & uterine cervix, & melanomas of the skin, rectovaginal cancer, larynx & thyroid cancer, Ewing sarcoma, etc. [which includes all 20 most frequent cancers in Thailand]. The estimated overall 5-year survival rate of all of these cancer patients, almost all of them terminal with widespread metastasis [see (a)] & [seeking our treatment only] after all conventional treatments had been exhausted, was ~40%, which increased to ~50% if they survived the first 3 weeks after treatment onset, & to ~60% if they survived 3 months after treatment onset, even more, ~80%, if they had a chance to have follow-up treatments at LSU, which was denied to virtually all patients after 17 July 1998 & until mid-2003, and many of which would be alive today; and while the estimated 5 year survival of untreated [with conventional methods: surgery &/or radiation &/or chemotherapy, etc.] patients was about 95% if they kept in touch with LSU/ULS, had a purpose to their lives with goals they absolutely needed to achieve, no matter what, meticulously maintained their alkalinizing blood-type-specific supplementation/diet/lifestyle, & balanced mind/ body/spirit as practitioners of Taoist Energy Healing, Silva Mind Control, & Neurolinguistic Programming (NLP).

Why is it essential that you stay in touch with us after completion of your initial treatment? Because we will use EVERY METHOD AVAILABLE to get & keep you well These methods, individually tailored to your specific needs, may include but are not limited to the following:

1. Herbal Electron Donors & Propagermanium (both for treatment & maintenance): The most effective herbal electron donors that restore the body to an alkaline balance can be found in plants containing high amounts of germanium (Ge). Medicinal plants that reputedly have anticancer activity and that contain high amounts of Ge include shelf fungus (Trametes cinnabarina; 800- 2000 ppm), Ginseng (Panax ginseng; 250-350 Korean < 4000ppm), garlic (Allium sativum; 750 ppm), d?ng-sh?n/sansukon root (Codonopsis pilosula; 260 ppm), sushi (Angelica pubescens; 260 ppm), Bandai moss (260 ppm), Japanese waternut (Trapa japonica: 240 ppm), Comfrey (Symphytum officinale; 150 ppm), boxthorn seed (Lycium chinense; 125 ppm), wisteria knob/gall (Wisteria floribunda; 110 ppm), pearl barley (fructus coicis lacryma-jobi; 75 ppm), etc. Based on this concept, Kazuhiko Asai synthesized numerous non-toxic Ge compounds, most notably, propagermanium or biscarboxyethyl Ge sesquioxide [O3(Ge.CH2.CH2.COOH)2], which has been found effective in the prevention and treatment of numerous cancers and their metastases including cancers of the lungs, prostate, breast, liver, kidney, brain tumors, lymphomas and leukemias, and sarcomas such as chondro- and osteosarcomas. The recommended dosage for prevention is 100 to 200 mg/day and for treatment 1000 to 4000 mg/day for a 60 kg patient. Except for a Herxheimer-type “healing crisis” reaction, no other adverse effects have been observed with this compound. If no effect is seen, the treatment should be discontinued after 60 days.

2. Other Proven Effective Herbal Combinations: Herbal treatments of cancer which were used worldwide since time immemorial include: Shark cartilage, Resistocell®, the thymus preparations Thymex L® and TFZ-Thymomodulin®, colostrum-derived transfer factor (TF) according to H. Hugh Fudenberg, Dr. Nieper¹s natural anticancer substances, and herbal cancer treatments such as compounded Hoksey [Trifolium pratense, Rhammus cathartica, Berberis vulgaris, Arctium lappa, Stillingia sylvatica, Rhammus purshiana or Cascara amarga (Sweetia panamensis), Glycyrrhiza glabra, Zanthoxylum clava-herculis], compounded Echinacea [Echinacea spp, Ceanothus americanus, Baptisia tinctoria, Thuja occidentalis, Stillingia sylvatica, Iris versicolor, Zanthoxylum clava-herculis], Folia Thujae occidentalis (fresh), Radix Astragali membranacei (Huáng Qí), Radix Rumicis crispi (fresh), and Renèe Caisse’s Essiac compound [Rumex acetosella, Arctium lappa (fresh root), Ulmus rubra, Rheum palmatum (root), etc.], PDR Cancer Formula [Larrea divaricata (folia), Sanguinaria canadensis (radix), Trifolium pratense (flores), Arcticum lappa (radix); Echinacea purpurea (radix), Hydrastis canadensis (radix); Symphytum officinale (folia), Eleutherococcus senticosus (radix; eventually folia, radix, and flores), Chelidonium maius, combined with Artemisia absinthium, Yucca spp, and Commiphora molmol (gum), C. abyssinica (myrrh), or C. opobalsamum (bdellium-oleoresin)], Laetrile® et al. mandelonitriles, immunostimulating mushroom extracts from Grifola frondosa (maitake), Ganoderma lucidum (reishi), and Lentinusedodes (shiitake), combined with herbs for specific cancers; e.g., herba Hedyotis diffusae (bái hu? shé c?o) combined with herba Scutellariae barbatae (bàn zh? lían) for stomach, esophageal, & colon cancers , & the latter alone for lung cancers, & tuber Dioscoreae bulbiferae (huáng yào z?) for thyroid cancer & endemic goiter, and, especially, Haelan 851® Platinum Formula and Natures Blessing.

3. WILL TO LIVE – MENTAL RECONDITIONING: What virtually all cancer survivors, particularly the ones that had been undergoing conventional therapies, have in common is that they had a purpose to their lives with goals they absolutely needed to achieve, no matter what. If counseling
is successful in restructuring an individual’s outlook on life along those lines considerable life extensions beyond all expectations can be achieved after conventional therapies, while with the enhanced high pH therapy, the success is virtually guaranteed, provided that the patient has survived the first three months after the treatment started, and that they followed the programs outlined under 4. Conventional cancer treatment attempts, particularly surgery, that may in many cases frustrate all efforts to restore the will to live include colostomies, crippling lung resections, amputations of limbs, especially in children, cosmetically poor results after head, neck, & breast surgery &/or radiation. The same applies to paralysis after collapse of vertebrae from metastasis or from brain malignancies. Continued next page

4. DIET & LIFESTYLE: Meticulously maintaining their prescribed alkalinizing blood type specific diet, supplementation, exercise program, and lifestyle is as essential as mental reconditioning [see 3.] and energy balancing [see 5.]. Individualized supplementation may include maintenance doses of cesium & rubidium, potassium & magnesium salts, Wobemugos, bromelain, papain, superoxide dismutase (SOD), & other enzymes, coenzyme Q10, vitamin A & beta-carotene, selenium & vitamin E, vitamin C, quercetin, & isoflavones, lycopene, N-acetyl cystein (NAC), pycnogenol, d-limonene, curcumin, alpha lipoic acid, inositol, methylsulfonylmethane (MSM), ellagic acid & graviola (Annona muricata), Primal Defense, Nature’s Blessing, green tea, olive leaf extract, echinacea, garlic, parsley, Korean ginseng, apricot pits, wheat grass, chlorella, cod & shark liver oils, contortrostatin, carrot & cabbage juices, mogu (Kompucha) tea, regular escargots & soy bean products for blood type As & ABs, and over 20 other cancer fighting foods according to your blood type & individually tailored to specific needs. The blood type specific diet & exercise program follows largely the one outlined in Dr. Peter J. D’Adamo’s book “Live Right Four Your Type”, modified & amplified based on our own research including avoidance of sugar & fructose ( & all refined carbohydrates) by all types, particularly Os & Bs, avoidance of cow’s milk, particularly Os & As, avoidance of the foods shown harmful for all types including pork, etc. All these programs have been streamlined and are available through people I have trained and shown a dedication to the ongoing development of High PH Therapy. With the most well structured program being available through Paul Rana of The RANA System in Australia, Dr Pablo at XYZ-Wellbeing Retreat Facility and Dr Sherrie in India.

____________________________________

Abdul-Haqq H.E. Sartori, M.D

Page 4 of 5

Prof. Abdul-Haqq Sartori, M.D. Medicina Alternativa Professor of Alternative Medicines

RE: Enhanced High-pH Therapy for Cancer now available through trained Practitioner at XYZ Wellbeing ReTreat Facility founded in the year 2000 and undergoing a major refit and expansion in late 2008.

Thank you for contacting me to enquire about Cesium chloride (CsCl) and the Enhanced High-pH Therapy for Cancer originated by A. Keith Brewer, Ph.D., and since 1980 enhanced and perfected by myself.

Though the results were published in a major peer-reviewed medical journal, Pharmacology, Biochemistry, and Behavior in the December 1984 Supplement I, there was, except for the late Dr. Hans Nieper, a minimum of response from both the orthodox and alternative medical community.

Therefore, unfortunately, I am the only physician left who uses this by far most consistently effective therapy for all fast-growing cancers that have been treated so far, no matter what stage or type or extent. So as I am aging, I have trained a few people the correct and safe way to use this therapy. Do not be experimented on, my many years of research are beyond reproach.

Please read all my notes before you undertake any program. Since 1980, over 700 cancer patients have been treated with this therapy. In all cases, fast-growing tumors were promptly reduced in size with minimum discomfort to the patient (as compared to the common and sometimes horrendous adverse effects of chemotherapy and after radiation). With the intravenous (I.V.) application of this therapy, we consistently achieved primary & metastatic tumor reductions of 1.0 to 2.0 cm (2/5 to 2/5 of an inch) per day, i.e., disappearance of 5.0 cm (2.0) tumors in about four days, and of 10.0 cm (4.0) tumors in about eight days, and reductions of lymph node metastases of 2-5 mm/day.

Besides the higher and more consistent effectiveness, I.V. application of CsCl and other minerals, vitamins, mandelonitriles (e.g., Laetrile®), etc., avoids all side effects from oral therapy such as nausea, vomiting, diarrhea, abdominal discomfort, etc. Furthermore, I.V. application guarantees that all ingredients are taken up by the body, as often nutrient absorption may be compromised, particularly in patients with any type of malabsorption from gastrointestinal problems or in many advanced cancers or simply from lack of hydrochloric acid.

The only side effects seen with this therapy is the sometimes considerable, but brief, discomfort from the I.V. application of Ozone that is, in fact, a most beneficial homeopathic-type healing crisis. Best of all, this healing crisis reverses virtually all tendencies towards any type of illness and, in due time, almost all patients report that have “never felt better” in their entire life. In a tireless effort, Paul Rana, since 1998, developed most effective and comprehensive system in preparation for and as follow up of the Enhanced High pH Therapy.

The Rana System is an integral part of our therapy and you should follow it for at least one year or, preferably, for the rest of your life. Following this System gives you not only the highest success rates in permanently overcoming cancer but also greatly enhances your overall health, happiness, vigor, and longevity. For more information about The RANA SYSTEM and how to become a member, please consult with Paul Rana or peruse his websites in Australia.

I have passed on The RANA System research papers and system manuals with permission to www.xyz-wellbeing.com team 1995, early results are exciting to say the very least and the upgrade of a ReTreat Facility in Colombia is scheduled in 2008. Contact Dr Pablo at xyz for details.The Enhanced High-pH Therapy for cancer within the framework of The XYZ Wellbeing ReTreat System is now available in Colombia at a fraction of the financial costs of any conventional therapy that, besides very poor results in most cancers, causes severe suffering and in many cases permanent damages, and is the main cause for premature deaths in cancer patients. Since 1970, the start of President Nixon’s War on Cancer, the yearly death rate in the U.S.A. went up from 135,000 to over 800,000 and the average cost per patient is around US$ 300,000.00 ($ 100,000 to over $ 1,000,000.00) with an average out of pocket expenses for insured patients of about $ 60,000.00 ($ 20k to >200k).

Compared with this, the total all-inclusive investment for six to nine weeks of treatment in Colombia including the Enhanced High-pH Therapy for cancer (with room & board for a companion) and ongoing follow-up, as well as setup & three months of all supplements. They have designed a three month in house and 3 month follow up program that is under research that includes the best combination of services and the most determined team I have seen. If you are one of those patients that seek us out first when their primary tumor is less than 5.0 cm (2.0″) in diameter (and which have not yet undergone any conventional treatment), they should offer you a special price.

Also enclosed are my letters o